triazoles has been researched along with Merkel Cell Cancer in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bartley, BR; Doan, HQ; Moore, SA; Narayanan, D; Rady, PL; Simonette, RA; Tyring, SK | 1 |
| Doan, HQ; Gupta, R; Rady, PL; Simonette, RA; Tyring, SK | 1 |
| Gao, L; Kannan, A; Lin, Z; Shao, Q; Stack, BC; Suen, JY | 1 |
| Gao, L; Kannan, A; Kern, M; Moreno, MA; Sengupta, D; Stack, B; Suen, JY; Tackett, AJ; Vural, E | 1 |
| Fang, B; Gao, L; Kannan, A; Kannan, K; Lin, Z; Moreno, MA; Shao, Q; Stack, BC; Suen, JY; Vural, E; Zhao, S | 1 |
| Brown, M; O'Reilly Zwald, F | 1 |
1 review(s) available for triazoles and Merkel Cell Cancer
| Article | Year |
|---|---|
Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.
Topics: Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Education, Medical, Continuing; Female; Humans; Immunocompromised Host; Incidence; Male; Melanoma; Organ Transplantation; Prognosis; Pyrimidines; Risk Assessment; Sarcoma, Kaposi; Sirolimus; Skin Neoplasms; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2011 |
5 other study(ies) available for triazoles and Merkel Cell Cancer
| Article | Year |
|---|---|
Selinexor is a novel inhibitor of DNA damage response in Merkel cell carcinoma.
Topics: Carcinoma, Merkel Cell; DNA Damage; Humans; Hydrazines; Merkel cell polyomavirus; Skin Neoplasms; Triazoles | 2022 |
Targeting the expression of T antigens with selinexor (KPT-330) shows promise for Merkel cell polyomavirus-positive Merkel cell carcinoma treatment.
Topics: Antigens, Viral, Tumor; Carcinoma, Merkel Cell; Humans; Hydrazines; Merkel cell polyomavirus; Polyomavirus Infections; Skin Neoplasms; Triazoles; Tumor Virus Infections | 2021 |
BET protein inhibitor JQ1 attenuates Myc-amplified MCC tumor growth in vivo.
Topics: Animals; Azepines; Carcinoma, Merkel Cell; Cell Line; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Nuclear Proteins; Proto-Oncogene Proteins c-myc; Signal Transduction; Triazoles; Xenograft Model Antitumor Assays | 2014 |
Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
Topics: Acetylation; Animals; Apoptosis; Azepines; Carcinoma, Merkel Cell; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chromatin; Enhancer Elements, Genetic; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Jumonji Domain-Containing Histone Demethylases; Mice; Neoplasm Metastasis; Nuclear Proteins; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-myb; Skin Neoplasms; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays | 2015 |
Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth.
Topics: Animals; Apoptosis; Azepines; Benzoxazoles; Blotting, Western; Carcinoma, Merkel Cell; Cell Proliferation; Cellular Senescence; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Pyrimidines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; TOR Serine-Threonine Kinases; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |